These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 21835298

  • 1. The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
    Hage FG, Dean P, Bhatia V, Iqbal F, Heo J, Iskandrian AE.
    Am Heart J; 2011 Aug; 162(2):356-62. PubMed ID: 21835298
    [Abstract] [Full Text] [Related]

  • 2. Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
    Iqbal FM, Al Jaroudi W, Sanam K, Sweeney A, Heo J, Iskandrian AE, Hage FG.
    Am J Cardiol; 2013 Jan 15; 111(2):190-5. PubMed ID: 23111139
    [Abstract] [Full Text] [Related]

  • 3. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.
    Hage FG, Heo J, Franks B, Belardinelli L, Blackburn B, Wang W, Iskandrian AE.
    Am Heart J; 2009 Apr 15; 157(4):771-6. PubMed ID: 19332209
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of abnormal heart rate recovery on exercise stress testing to predict high-risk findings on single-photon emission computed tomography myocardial perfusion imaging in men.
    Gera N, Taillon LA, Ward RP.
    Am J Cardiol; 2009 Mar 01; 103(5):611-4. PubMed ID: 19231321
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.
    Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, Chang SM.
    Circulation; 2008 Dec 09; 118(24):2540-9. PubMed ID: 19047585
    [Abstract] [Full Text] [Related]

  • 6. Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome.
    Hage FG, Perry G, Heo J, Iskandrian AE.
    Am J Cardiol; 2010 Mar 15; 105(6):839-43. PubMed ID: 20211328
    [Abstract] [Full Text] [Related]

  • 7. The impact of chronic kidney disease as a predictor of major cardiac events in patients with no evidence of coronary artery disease.
    Furuhashi T, Moroi M, Joki N, Hase H, Masai H, Kunimasa T, Nakazato R, Fukuda H, Sugi K.
    J Cardiol; 2010 May 15; 55(3):328-36. PubMed ID: 20350504
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.
    Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I.
    Circulation; 2007 Apr 03; 115(13):1769-76. PubMed ID: 17353441
    [Abstract] [Full Text] [Related]

  • 9. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.
    Rashidi A, Sehgal AR, Rahman M, O'Connor AS.
    Am J Cardiol; 2008 Dec 15; 102(12):1668-73. PubMed ID: 19064021
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 11. Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease.
    Hakeem A, Bhatti S, Karmali KN, Dillie KS, Cook JR, Xu J, Samad Z, Chang SM.
    JACC Cardiovasc Imaging; 2010 Jul 20; 3(7):734-45. PubMed ID: 20633852
    [Abstract] [Full Text] [Related]

  • 12. Beta-blockers for coronary heart disease in chronic kidney disease.
    Chonchol M, Benderly M, Goldbourt U.
    Nephrol Dial Transplant; 2008 Jul 20; 23(7):2274-9. PubMed ID: 18187497
    [Abstract] [Full Text] [Related]

  • 13. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, Stabryła-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.
    Kardiol Pol; 2007 Jun 20; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [Abstract] [Full Text] [Related]

  • 14. A multidimensional approach to the geriatric patient with chronic kidney disease.
    Pilotto A, Sancarlo D, Franceschi M, Aucella F, D'Ambrosio P, Scarcelli C, Ferrucci L.
    J Nephrol; 2010 Jun 20; 23 Suppl 15():S5-10. PubMed ID: 20872364
    [Abstract] [Full Text] [Related]

  • 15. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.
    Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE.
    J Nucl Cardiol; 2011 Dec 20; 18(6):1086-94. PubMed ID: 21785922
    [Abstract] [Full Text] [Related]

  • 16. Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study.
    Kobayashi M, Hirawa N, Morita S, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, Toya Y, Yasuda G, Umemura S.
    Am J Kidney Dis; 2010 Sep 20; 56(3):468-76. PubMed ID: 20537454
    [Abstract] [Full Text] [Related]

  • 17. Effects of a myocardial ischaemia-guided therapeutic program on survival and incidence of coronary events in asymptomatic patients with diabetes: the ARCADIA study.
    Vanzetto G, Boizel R, Halimi S, Ormezzano O, Belle L, Fagret D, Machecourt J.
    Diabetes Metab; 2007 Dec 20; 33(6):459-65. PubMed ID: 17977767
    [Abstract] [Full Text] [Related]

  • 18. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E, AlJaroudi WA, Farag A, Lester D, Patel H, Iskandrian AE, Hage FG.
    Eur J Nucl Med Mol Imaging; 2016 Jul 20; 43(8):1493-502. PubMed ID: 27079736
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.
    Wattanakit K, Coresh J, Muntner P, Marsh J, Folsom AR.
    J Am Coll Cardiol; 2006 Sep 19; 48(6):1183-9. PubMed ID: 16979003
    [Abstract] [Full Text] [Related]

  • 20. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD.
    Pacing Clin Electrophysiol; 2007 Feb 19; 30(2):207-13. PubMed ID: 17338717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.